Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 May 11;23(1):859.
doi: 10.1186/s12889-023-15749-x.

Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

Xuanxuan Niu  1 , Lin Zhu  1 , Yifan Xu  1 , Menghan Zhang  1 , Yanxu Hao  1 , Lei Ma  1 , Yan Li  1 , Huichun Xing  2   3
Affiliations
Meta-Analysis

Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

Xuanxuan Niu et al. BMC Public Health. .

Erratum in

Abstract

Background: Alcohol related liver disease (ARLD) is one of the major chronic liver diseases worldwide. This review aimed to describe the global prevalence, incidence, and outcomes of ARLD.

Methods: Medline, Embase, The Cochrane Library, and China National Knowledge Infrastructure (CNKI) were searched from inception to May 31, 2022. The language was restricted to English or Chinese. According to the criteria, articles describing the basic characteristics of the population were selected. Two reviewers extracted the data independently.

Results: A total of 372 studies were identified: 353 were used for prevalence analysis, 7 were used for incidence analysis, and 114 were used to for outcome analysis. The prevalence of ARLD worldwide was 4.8%. The prevalence in males was 2.9%, which was higher than female (0.5%). Among the ethnic groups, the percentage was highest in Caucasians (68.9%). Alcoholic liver cirrhosis comprised the highest proportion in the disease spectrum of ARLD at 32.9%. The prevalence of ascites in ARLD population was highest (25.1%). The ARLD population who drinking for > 20 years accounted for 54.8%, and the average daily alcohol intake was 146.6 g/d. About 59.5% of ARLD patients were current or former smokers, and 18.7% were complicated with hepatitis virus infection. The incidence was 0.208/1000 person-years. The overall mortality was 23.9%, and the liver-related mortality was 21.6%.

Conclusion: The global prevalence of ARLD was 4.8% and was affected by sex, region, drinking years, and other factors. Therefore, removing the factors causing a high disease prevalence is an urgent requisite.

Trial registration: PROSPERO Nr: CRD42021286192.

Keywords: Alcohol related liver diseases; Epidemiology; Prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study selection. The entire screening process were described, including the selected the reasons for the exclusion of articles and the number of including and excluding artcles. ARLD: alcohol-associated liver disease. HBV: hepatitis B virus. HCV: hepatitis C virus. HIV: human immunodeficiency virus. DILI: drug-induced liver injury.* Some articles were used for more than one of the analyses of prevalence, incidence, and outcomes. # When searching for relevant articles found 4 additional articles that met the inclusion criteria
Fig. 2
Fig. 2
The global prevalence of ARLD. The prevalence in 14 countries was indicated by depth of red. The 14 countries included Portugal, Canada, Iceland, France, China, USA, Denmark, South Korea, Uganda, India, UK, Sweden, Japan, and Italy
Fig. 3
Fig. 3
The prevalence of ARLD in China by provinces. The prevalence in 21 provinces of China was indicated by depth of red. The prevalence in China was obtained from the analysis of 21 cities or provinces including Sichuan, Beijing, Guangdong, Jiangsu, Shanghai, Gansu, Shaanxi, Guizhou, Zhejiang, Henan, Hunan, Jilin, Heilongjiang, Taiwan, Tibet, Liaoning, Yunnan, Anhui, Shandong, Hebei, and Xinjiang provinces
See this image and copyright information in PMC

References

    1. Global status report on alcohol and health 2018 [https://www.who.int/substance_abuse/publications/global_alcohol_report].
    1. Ding C, O'Neill D, Bell S, Stamatakis E, Britton A. Association of alcohol consumption with morbidity and mortality in patients with cardiovascular disease: original data and meta-analysis of 48,423 men and women. BMC Med. 2021;19(1):167. - PMC - PubMed
    1. Buckley C, Ye Y, Kerr WC, Mulia N, Puka K, Rehm J, Probst C. Trends in mortality from alcohol, opioid, and combined alcohol and opioid poisonings by sex, educational attainment, and race and ethnicity for the United States 2000–2019. BMC Med. 2022;20(1):405. - PMC - PubMed
    1. Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, Xu Y, Liu Y, Li W, Koike K, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–221. - PubMed
    1. Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. - PMC - PubMed

Publication types